Liberty All-Star Equity Fund (USA) Competitors $6.96 +0.14 (+2.05%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends USA vs. IBB, DNP, HTGC, ADX, PTY, RVT, TY, GAB, STEW, and GSBDShould you be buying Liberty All-Star Equity Fund stock or one of its competitors? The main competitors of Liberty All-Star Equity Fund include iShares Biotechnology ETF (IBB), DNP Select Income Fund (DNP), Hercules Capital (HTGC), Adams Diversified Equity Fund (ADX), PIMCO Corporate & Income Opportunity Fund (PTY), Royce Value Trust (RVT), Tri-Continental (TY), The Gabelli Equity Trust (GAB), SRH Total Return Fund (STEW), and Goldman Sachs BDC (GSBD). These companies are all part of the "investment offices, not elsewhere classified" industry. Liberty All-Star Equity Fund vs. iShares Biotechnology ETF DNP Select Income Fund Hercules Capital Adams Diversified Equity Fund PIMCO Corporate & Income Opportunity Fund Royce Value Trust Tri-Continental The Gabelli Equity Trust SRH Total Return Fund Goldman Sachs BDC Liberty All-Star Equity Fund (NYSE:USA) and iShares Biotechnology ETF (NASDAQ:IBB) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends. Do insiders & institutionals believe in USA or IBB? 9.9% of Liberty All-Star Equity Fund shares are owned by institutional investors. Comparatively, 62.5% of iShares Biotechnology ETF shares are owned by institutional investors. 0.1% of Liberty All-Star Equity Fund shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer USA or IBB? iShares Biotechnology ETF has a consensus price target of $132.73, suggesting a potential upside of 0.00%. Given iShares Biotechnology ETF's stronger consensus rating and higher probable upside, analysts plainly believe iShares Biotechnology ETF is more favorable than Liberty All-Star Equity Fund.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liberty All-Star Equity Fund 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00iShares Biotechnology ETF 0 Sell rating(s) 8 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.64 Which has stronger earnings & valuation, USA or IBB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiberty All-Star Equity Fund$355.30M5.31N/AN/AN/AiShares Biotechnology ETFN/AN/AN/AN/AN/A Does the media favor USA or IBB? In the previous week, Liberty All-Star Equity Fund had 1 more articles in the media than iShares Biotechnology ETF. MarketBeat recorded 2 mentions for Liberty All-Star Equity Fund and 1 mentions for iShares Biotechnology ETF. Liberty All-Star Equity Fund's average media sentiment score of 0.23 beat iShares Biotechnology ETF's score of -1.00 indicating that Liberty All-Star Equity Fund is being referred to more favorably in the media. Company Overall Sentiment Liberty All-Star Equity Fund Neutral iShares Biotechnology ETF Negative Does the MarketBeat Community favor USA or IBB? Liberty All-Star Equity Fund received 164 more outperform votes than iShares Biotechnology ETF when rated by MarketBeat users. Likewise, 68.87% of users gave Liberty All-Star Equity Fund an outperform vote while only 67.09% of users gave iShares Biotechnology ETF an outperform vote. CompanyUnderperformOutperformLiberty All-Star Equity FundOutperform Votes32368.87% Underperform Votes14631.13% iShares Biotechnology ETFOutperform Votes15967.09% Underperform Votes7832.91% Is USA or IBB a better dividend stock? Liberty All-Star Equity Fund pays an annual dividend of $0.71 per share and has a dividend yield of 10.2%. iShares Biotechnology ETF pays an annual dividend of $0.51 per share and has a dividend yield of 0.4%. Is USA or IBB more profitable? Company Net Margins Return on Equity Return on Assets Liberty All-Star Equity FundN/A N/A N/A iShares Biotechnology ETF N/A N/A N/A Which has more risk & volatility, USA or IBB? Liberty All-Star Equity Fund has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, iShares Biotechnology ETF has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. SummaryLiberty All-Star Equity Fund beats iShares Biotechnology ETF on 8 of the 12 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Liberty All-Star Equity Fund News Delivered to You Automatically Sign up to receive the latest news and ratings for USA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart USA vs. The Competition Export to ExcelMetricLiberty All-Star Equity FundInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$1.89B$8.38B$11.19B$19.18BDividend Yield10.00%6.75%9.81%3.61%P/E RatioN/A0.4427.9541.30Price / Sales5.3114.7938.5217.60Price / CashN/A7.0318.6321.28Price / BookN/A0.882.755.32Net IncomeN/A$73.96M$1.04B$989.88M7 Day Performance-2.52%-2.96%-2.88%-3.54%1 Month Performance-3.20%-2.31%-2.88%-3.68%1 Year Performance9.87%3.73%11.52%12.14% Liberty All-Star Equity Fund Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)USALiberty All-Star Equity FundN/A$6.96+2.1%N/A+10.3%$1.89B$355.30M0.00N/ANews CoverageIBBiShares Biotechnology ETFN/A$137.22+0.4%N/A+3.0%$6.93BN/A0.00N/ADividend CutEx-DividendNegative NewsDNPDNP Select Income FundN/A$9.23-0.6%N/A+8.8%$3.31B$-131,428,204.000.00590Dividend AnnouncementHTGCHercules Capital1.3189 of 5 stars$19.30-0.6%$20.90+8.3%+18.5%$3.14B$460.67M9.61100ADXAdams Diversified Equity FundN/A$20.64+0.7%N/A+16.8%$2.56B$639.96M0.0030PTYPIMCO Corporate & Income Opportunity FundN/A$14.54flatN/A+6.9%$2.23B$211.84M0.00147,000RVTRoyce Value TrustN/A$15.91+0.2%N/A+10.8%$1.84BN/A0.0050TYTri-ContinentalN/A$32.12+0.3%N/A+10.5%$1.73B$282.60M0.00N/AGABThe Gabelli Equity TrustN/A$5.51-1.4%N/A+10.4%$1.66BN/A0.00N/ANews CoveragePositive NewsSTEWSRH Total Return FundN/A$16.34-0.2%N/A+16.7%$1.58BN/A0.00N/AGSBDGoldman Sachs BDC1.7467 of 5 stars$12.73-1.1%$13.00+2.1%-15.3%$1.49B$90.89M18.39N/A Related Companies and Tools Related Companies IBB Alternatives DNP Alternatives HTGC Alternatives ADX Alternatives PTY Alternatives RVT Alternatives TY Alternatives GAB Alternatives STEW Alternatives GSBD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:USA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liberty All-Star Equity Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share Liberty All-Star Equity Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
